This research service analyzes the market for the inherited disease molecular diagnostics markets. FDA-cleared genetic tests for CF and inherited thrombophilia are included. Key market drivers and restraints are ranked and discussed. Key technology and trends that will impact the market are identified. Revenue forecasts, a market share analysis, and a product analysis are also provided. The competitive structure is provided for cystic fibrosis test vendors, inherited thrombophilia test vendors, and laboratories that offer of cystic fibrosis testing. The major market challenges are outlined along with strategic recommendations to address them.

1. Executive Summary
- Market Overview
  - Introduction
2. Total Inherited Disease Molecular Diagnostics Market
- Market Overview
  - Introduction
  - Scope and Segmentation
  - Research Methodology
  - Market Engineering Measurements
- Market Challenges and Strategic Recommendations
  - Industry Challenges
  - Strategic Recommendations
- Market Drivers and Restraints
  - Market Drivers
  - Market Restraints
- Technology and Market Trends
  - Technology and Market Trends
- Market Forecasts and Competitive Analysis
  - Revenue Forecasts
  - Competitive Structure - Cystic Fibrosis Test Vendors
  - Competitive Structure - Cystic Fibrosis Test Services
  - Competitive Structure - Inherited Thrombophilia Test Vendors
  - Market Share Analysis - Cystic Fibrosis Test Vendors
  - Market Share Analysis - Inherited Thrombophilia Test Vendors
  - Product Analysis - Inherited Disease Molecular Diagnostics Tests and Platforms
  - Product Analysis - Cystic Fibrosis Tests
  - Product Analysis - Inherited Thrombophilia Tests

Pharmaceutical Market Research

U.S. Inherited Disease Molecular Diagnostics Markets

U.S. Inherited Disease Molecular Diagnostics Markets

Contents

Related products